Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3814841 | 1.00 | — | — | |
| SCHEMBL5606390 | 1.00 | — | — | |
| SCHEMBL4901795 | 1.00 | TSHR (0.50) | TSHRALDH1A1MAPK1TDP1TRPA1 | |
| SCHEMBL10862 | 1.00 | — | — | |
| SCHEMBL2430668 | 1.00 | TSHR (0.50) | TSHRALDH1A1MAPK1TDP1TRPA1 | |
| Hydrogen Sulfide SCHEMBL6569480 | 0.95 | — | — | |
| SCHEMBL7943710 | 0.95 | — | — | |
| Ethylene SCHEMBL76814 | 0.95 | — | — | |
| SCHEMBL11303058 | 0.95 | — | — | |
| Iodide SCHEMBL8019411 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7317130-B2 | Method for the hydroformylation of olefinically unsaturated compounds, especially olefins, in the presence of cyclic carbonic acid esters | OXENO OLEFINCHEMIE GMBH (DE) | 2008-01-08 | — | — | US | disclosed |
| US-20060241324-A1 | Method for the hydroformylation of olefinically unsaturated compounds, especially olefins,in the presence of cyclic carbonic acid esters | OXENO OLEFINCHEMIE GMBH (DE) | 2006-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060241324-A1 | Method for the hydroformylation of olefinically unsaturated compounds, especially olefins,in the presence of cyclic carbonic acid esters | ELOVL6, ELOVL1, ELOVL5 | TSHR 3682/4885ALDH1A1 173/4885MAPK1 3944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.